This piece explores how sweeping U.S. budget cuts to science and healthcare research are triggering a brain drain, with top researchers and critical studies—especially those impacting women’s health—moving abroad. It highlights the downstream effects on innovation, startups, and public health, warning that these losses may be irreversible and disproportionately harmful to underserved populations.